On Friday, the two chambers of Virginia's General Assembly passed marijuana legalization bills. The two must be reconciled for consistency's sake; afterward, the combined version will be sent to legalization supporter Gov. Ralph Northam for his signature. So what fueled the great enthusiasm for marijuana stocks on Monday? it was the increasing likelihood that...
OLB Group Announces Plan to Offer Cryptocurrency Payment Options via Blockchain Technology on its OMNICOMMERCE Platform and SecurePay TM Gateway OLB’s SecurePay TM Payment Gateway to Enable Merchants to Seamlessly Offer Cryptocurrency Payments $OLB upgraded its SecurePay payment gateway system to support Cryptocurrencies including Bitcoin, Ethereum, USDC and DAI...
Jazz Pharmaceuticals $JAZZ agreed to buy GW Pharmaceuticals $GWPH for $7.2 billion last wednesday sending shares of fellow epilepsy-focused biotech companies $ZYNE flying. "The acquisition allows Jazz to become a significant epilepsy player by adding Epidiolex, which exited 2020 with sales annualizing at about $576 million despite a challenging Covid environment...
Why $AYRO Anchiano Therapeutics Surged yesterday? Thanks to some news in January, $AYRO stock is racing higher. So what was that news? And what else do you need to know? $AYRO is captivating investors thanks to its $20 Million Registered Direct Offering with Two Existing Investors news on January 25. Announced that it has entered into definitive agreements...
Why $RKDA Skyrocketed yesterday There does not appear to be any direct news from the company. But it seems like that there was some coordination by day traders on social media. $RKDA shares were buoyed — thanks to discussions stock trading groups on Twitter and Twitter hashtags, before the market opened. Hemp/Pot play, Similar to $TLRY move from $3 to $50 has...
Tilray® Announces Agreement with Grow Pharma to Import and Distribute Medical Cannabis Products in the United Kingdom Grow Pharma will distribute Tilray’s GMP-certified medical cannabis products across the UK New UK agreement gives doctors and patients access to a sustainable supply of Tilray’s pharmaceutical-grade medical cannabis products Tilray expects to...
Hyping on twitter: Traders Citing Monday Filing Mentioning Proposed Merger of Co With StemoniX Q1 merger play 6.5m float. Three different 13G's filed in the last few days two 10% and one 5% www.marketscreener.com
Why $ANCN Anchiano Therapeutics Is Surging Today? Thanks to some news in December in the biopharma space, $ANCN stock is racing higher. So what was that news? And what else do you need to know? $ANCN Anchiano Therapeutics is captivating investors thanks to its Definitive Merger Agreement with Chemomab news in december. The proposed merger will create a public...
Bio-Path Receives Third U.S. Patent Grant Related to Manufacture of Platform Technology Provides Expanded Protection to Seminal Patents Related to DNAbilize The new patent builds on earlier patents granted that protect the platform technology for DNAbilize®, the Company’s novel RNAi nanoparticle drugs. finance.yahoo.com
Globalstar’s Band n53 in Qualcomm’s X65 Modem Qualcomm to Include Band N53 in New 5G Flagship Modem The X65 is Qualcomm's flagship 5G modem and adds global 5G band support for n53. The X65 also offers greater 5G deployment flexibility with increased spectrum aggregation options. finance.yahoo.com
Why $CHCI Skyrocketed 270% yesterday There does not appear to be any direct news from the company. But it seems like that there was some coordination by day traders on social media. ATA shares were buoyed — thanks to discussions stock trading groups on Twitter and Twitter hashtags, before the market opened.
$KALV KalVista Pharmaceuticals Reports Positive Results for KVD900 Phase 2 Demonstrating Statistically and Clinically Significant Responses Across All Endpoints as an Oral On-Demand Treatment for HAE Attacks – Oral KVD900 Primary Endpoint Shows Only 15% Use of Rescue Medication in Patients with Hereditary Angioedema (HAE) – – KVD900 Generally Safe and...
Applied UV Announces Acquisition of the Airocide(R) Technology Platform for Airborne Pathogen Reduction Developed with NASA as a patented pathogen killing technology Proprietary photocatalytic oxidation process thoroughly destroys viruses, bacteria, spores, and fungi as well as other carbon-based molecules Airocide® air disinfection technology compliments and...
Hyping on twitter: H.C. Wainwright reiterates Buy, $25 price target on Purple Biotech H.C. Wainwright analyst Raghuram Selvaraju reiterates a Buy rating on Purple Biotech with a $25 price target following the name change from Kitov. The analyst says the company is advancing first-in-class oncology therapies. Purple recently initiated Phase 1/2 clinical studies...
Zomedica Corp. Increases Previously Announced Bought Deal Offering of Common Shares to $173.5 Million. today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 91,315,790 common shares of Zomedica, at a price to the public of $1.90 per share, less...
Hyping on twitter: Added New position $OPGN primarily for the top catalyst FDA decision Acuitas AMR Gene Panel. In addition, pipeline includes Broad pathogen and Antimicrobial Resistance Marker coverage. 53 M market cap. Eyeing $3.3 breakout target towards $4 plus. Should spike on FDA decision. twitter.com
Outlook Therapeutics Increases Previously Announced Bought Deal Offering of Common Stock to $35.0 Million announced today that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 35,000,000 shares of common stock of Outlook Therapeutics, at a price to the public of...
Sino-Global Shipping America Announces Pricing of Approximately $13.6 million Registered Direct Offering Priced At-The-Market announced today that it has entered into a securities purchase agreement with certain accredited investors to purchase approximately $13.6 million worth of its common stock in a registered direct offering and warrants to purchase common...